Zymofix Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
35
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$4.62M
- Investors
-
7
Zymofix General Information
Description
Developer of microbial enzyme products designed to replace chemical inputs in industrial and agricultural processes. The company offers high-purity enzymes produced through proprietary fermentation, customizable formulations, and decentralized production capabilities, enabling agricultural and industrial clients to adopt sustainable, efficient, and scalable alternatives that improve process performance and reduce environmental impact.
Contact Information
Website
www.zymofix.comCorporate Office
- Kerrebroek 66B
- 9850 Deinze
- Belgium
Corporate Office
- Kerrebroek 66B
- 9850 Deinze
- Belgium
Zymofix Timeline
Zymofix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC (Series A) | 25-Aug-2026 | $4.62M | Completed | Generating Revenue | ||
| 4. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 3. Early Stage VC | 12-Nov-2024 | Completed | Generating Revenue | |||
| 2. Grant | 21-Jun-2023 | $2.7M | $283K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-Jan-2022 | $283K | $283K | Completed | Generating Revenue |
Zymofix Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A Preferred | ||||||||
| Preference | ||||||||
| Ordinary | ||||||||
| Preference | 26,839 | $11.55 | $11.55 | 1x | $11.55 | 8.14% | ||
| Ordinary | 19,638 | $11.55 | $11.55 | 1x | $11.55 | 5.96% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Zymofix Patents
Zymofix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024170736-A1 | Microbial and nutrient delivery system | Inactive | 17-Feb-2023 |
Zymofix Signals
Zymofix Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| First Imagine! Ventures | Venture Capital | Minority | ||
| High-Tech Gründerfonds | Venture Capital | Minority | ||
| The Nest Family Office | Family Office | Minority | ||
| VP Capital (Goirle) | Family Office | Minority | ||
| European Innovation Council | Accelerator/Incubator | Minority |
Zymofix FAQs
-
When was Zymofix founded?
Zymofix was founded in 2022.
-
Where is Zymofix headquartered?
Zymofix is headquartered in Deinze, Belgium.
-
What is the size of Zymofix?
Zymofix has 35 total employees.
-
What industry is Zymofix in?
Zymofix’s primary industry is Specialty Chemicals.
-
Is Zymofix a private or public company?
Zymofix is a Private company.
-
What is the current valuation of Zymofix?
The current valuation of Zymofix is .
-
What is Zymofix’s current revenue?
The current revenue for Zymofix is .
-
How much funding has Zymofix raised over time?
Zymofix has raised $7.07M.
-
Who are Zymofix’s investors?
First Imagine! Ventures, High-Tech Gründerfonds, The Nest Family Office, VP Capital (Goirle), and European Innovation Council are 5 of 7 investors who have invested in Zymofix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process